chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The morning after she received the shot, her arm was hot to the touch, very red, and swollen. By that afternoon, her upper arm had swollen to almost twice its normal size, redness had spread down to her elbow and up to her neck(!!) and her arm was boiling hot. She cried for the next 3 days at school and at home about how much her arm hurt any time she moved, which was of course very often. She was in a lot of pain and did not sleep for 3 nights because of the pain. Even now, almost a week after the shot, although the redness has subsided and it's not as swollen, it is still swollen and uncomfortable.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date of 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX (Merck) which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse on 27-OCT-2014 who stated that it would take some time to get the  VARIVAX (Merck) information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she might send the information at a later time. Follow up information has been received from the registered nurse on 13-NOV-2014, concerning a patient (age reported as 6, units not provided) of unknown gender. On 28-OCT-2014, the patient was vaccinated with a dose of VARIVAX (Merck) which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Pfizer-BioNTech COVID-19 Vaccine EUA.  About 30 minutes after receiving his first dose of the Pfizer covid-19 vaccine, pt fell as a result of, "loosing his footing."  Pt fell on his left arm and was able to stand back up using his cane.  Pt's wife was with him and stated that he has had an increased incidence of falling lately and has an appointment with his physician to discuss.  Both the pt and his wife believe that the fall was not as a result from the vaccine.  However, since the fall happened shortly after receiving his vaccine am reporting.
Varicella - information has been received from a health care professional concerning a child who was vaccinated with one dose of varicella virus vaccine live.  The patient subsequently developed a breakthrough case of varicella.  The reporter stated that the child's varicella was not a severe case of breakthrough.  No further information is available.
Patient email: "After I got the injection.. My left arm was very sore and swollen as you said it would be. The next day the soreness and aches travelled from just my arm to my entire body (specifically my neck and back). I have been unable to lift my arm to 90 degrees without discomfort. I then passed out in the shower, was nauseous with GI upset, chills and low grade fever all day yesterday. Today I am starting to feel better and am back at work. My left arm soreness is improving and I am able to lift it better with less discomfort. My body aches continue, but no fever. Just achy lungs."
a metallic taste in mouth for one hour; This is a spontaneous report from non-contactable healthcare professional. A 79-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 5318) via an unspecified route of administration on 31Mar2021 as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. It was unknown if the patient had diagnosed with COVID-19 prior to vaccination. It was unknown if the patient had tested for COVID-19 since the vaccination. It was unknown if the patient had received any other vaccines within 4 weeks prior to the COVID vaccine. On 31Mar2021, the patient experienced a metallic taste in mouth for one hour. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of metallic taste was resolved on 31Mar2021 (for one hour).   No follow-up attempts are needed. No further information is expected.
a 29 year old male patient / inadvertently received the Shingrix vaccine; patient inadvertently received the Shingrix vaccine, the intended vaccine was the Moderna Covid-19; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 29-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th June 2021, the patient received Shingrix. On 15th June 2021, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.  Additional details were provided as follows: The pharmacist reported that, the 29 year old male patient inadvertently received the Shingrix vaccine, the intended vaccine was the Moderna Covid-19, which led to inappropriate age at vaccine administration and wrong vaccine administered. No further information was reported.
Fatigue; Muscle soreness; Low-grade fever; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK5730), via an unspecified route of administration in left arm on 24Mar2021 11:30 (at the age of 63-years-old) as dose 2, single for COVID-19 immunization. Medical history included none. Concomitant medication included multivitamin [vitamins nos]. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), via an unspecified route of administration in left arm on 03Mar2021 13:45 (at the age of 63-years-old) as dose 1, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not having allergies to medications, food, or other products. The patient experienced fatigue, muscle soreness, and low-grade fever on 24Mar2021 20:00. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of events was resolving.  No follow-up attempts are possible. No further information is expected.
PATIENT GOT THE SHOT ON WEDNESDAY AND FOUND OUT SATURDAY MORNIG THAT HIS ARM IS BUISING ABOUT PALM SIZE ON INJECTION SITE.
Patient was recieving a MMR injection when she pulled after feeling the injection going in. At that point a small droplet shot in my eye. After that I reported to my immediate chain of command and was treated via protocol.
Due to PT's vast history it was requested PT. be monitored. PT.'s history and vitals obtained and PT. monitored for 30 mins. PT. stated her Tongue was Tingling and Took her own Benadryl. After 30 mins. PT. was reexamined by Dr. & released. PT. advised to call 911 with any further issues
pt says one of her toes on her left foot went completely number.  Within a couple of days she started swelling between her left big toe and the toe next to it.  Her entire left foot started swelling and then her leg started swelling.  She went via ambulance to ER.  They did an US of her leg and found 2 blood clots in the back of calve.  She was given a RX for blood thinner.  She went to 3 pharmacies and could not find it so she went home.  She went home and then her right foot swelling as well.  She went back via ambulance to ER.  She was given blood thinner injection, and IV and took blood work.  Pt was admitted where she stayed for 5 days.  She was released and prescribed Eliquis.   She has to take 20 mg a day for first week and then 10mg a day the following week for 3 months.  She still has constant pain and her left foot continues to swell.  Pt will have to have another US in 3 months.
Information has been received from a physician concerning a 6-7 week old patient who in February 2007, was vaccinated PO with the first dose of Rotateq. The physician reported that in February 2007, within five days of being vaccinated, the patient developed loose stools/diarrhea and a urinary tract infection. Unspecified medical attention was sought and the patient was subsequently hospitalized (duration unknown). It was noted that blood and e-coli were found in the patient's stools. While hospitalized, the patient was treated with IV antibiotics and subsequently recovered. Additional information has been requested.
Pt rec'd vaccine and developed a red bump on area - it doesn't hurt and appears to be disappearing.
Patient was administered 2nd dose covid vaccine of Moderna after receiving 1st dose Pfizer. Pfizer was administered on 3/30/21 and Moderna was given on 4/22/21.
Chills-2 days Muscle aches-2days Headaches (intermittent) 2 weeks Dizziness, lightheaded (intermittently) -still occuring
Fatigue, joints ached, chills, slept 17 hours. Took 2 Tylenol PM and went to bed.
patients whose age is not within the recommended age group; Nervousness; Sore arm; Feeling jittery; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patients whose age is not within the recommended age group), NERVOUSNESS (Nervousness), PAIN IN EXTREMITY (Sore arm), FEELING JITTERY (Feeling jittery) and NAUSEA (Nausea) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (allergy to nuts) and Wheezing. Concomitant products included ALBUTEROL [SALBUTAMOL] from 07-Aug-2020 to an unknown date for Wheezing.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patients whose age is not within the recommended age group), NERVOUSNESS (Nervousness), PAIN IN EXTREMITY (Sore arm), FEELING JITTERY (Feeling jittery) and NAUSEA (Nausea). On 23-Mar-2021, NERVOUSNESS (Nervousness), PAIN IN EXTREMITY (Sore arm), FEELING JITTERY (Feeling jittery) and NAUSEA (Nausea) had resolved. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patients whose age is not within the recommended age group) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's race was updated as Black. Patient got her second dose on 01-APR-2021.  Treatment medications was not provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Reporter details, patient demographics, new events were updated.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number 029A21A) with no associated AEs reported.
Had small bump on arm and soreness for first couple days after shot, which went away.  On Sunday the 31st, I woke up with an itchy/burning sensation in area with a larger lump than what I had initially, and some minor redness in the area.  I took some Tylenol and applied ice pack, and also put some hydrocortisone cream on area for 2 -3 days.  By Thursday Feb, 4th, the area looked and felt much better - no lump and no more itching, no redness.  On Friday, Feb. 5th, I woke up to same itchy feeling, and there was a large area that was quite red.  I had an appointment with my primary care doctor for an unrelated issue, and she looked at the area and expressed concern since the redness was warm to the touch; however, I
Patient experienced some body aches starting the night after administration of the vaccine. She woke up the next morning with body sweats which then lead to vomiting. Patient states that she was on the floor with nonstop vomiting for most of the day. The next day she felt a little better but didn't eat anything. The following day she was back to her normal self again. Her husband had a similar experience but he didn't vomit until the 3rd day after administration (submitting another VAERS for him).
Very very sick; Very weak; Diarrhea; Itching; Fever 3 degrees up; Rash at the injection site; Swollen at the injection site; Very tired; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very very sick), ASTHENIA (Very weak), DIARRHOEA (Diarrhea), PRURITUS (Itching) and PYREXIA (Fever 3 degrees up) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had COVID-19 beginning of January.) and Sinusitis.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced ILLNESS (Very very sick), ASTHENIA (Very weak), DIARRHOEA (Diarrhea), PRURITUS (Itching), PYREXIA (Fever 3 degrees up), INJECTION SITE RASH (Rash at the injection site), INJECTION SITE SWELLING (Swollen at the injection site), FATIGUE (Very tired) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Mar-2021, ILLNESS (Very very sick), ASTHENIA (Very weak), DIARRHOEA (Diarrhea), PYREXIA (Fever 3 degrees up), INJECTION SITE RASH (Rash at the injection site), INJECTION SITE SWELLING (Swollen at the injection site), FATIGUE (Very tired) and NAUSEA (Nausea) had resolved. On 28-Mar-2021, PRURITUS (Itching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used included medicines for diabetes type 2.  Treatment medication included Tylenol.
Itching that is spreading across my body; warm sensation at injection site; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration (at the age of 41-years-old) on 28Jan2021 15:00 at a single dose in left arm for COVID-19 immunization. Medical history included high blood pressure. The patient's concomitant medications were not reported. The patient previously took Keflex [cefalexin] and experienced allergy. The patient experienced itching that is spreading across my body and warm sensation at injection site on 28Jan2021 16:00 with outcome of not recovered. Treatment was not received for adverse event. The patient was not pregnant at the time of vaccination. The events were considered as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Information on the lot/batch number has been requested.
Woke next morning with rash and itching on front lower neck and upper chest. Buring sensation to touch. Rash still present w/o change >72 hours. Recommended taking antihistamine and if no result trying topical steroid. Outcome pending
SKIN PEELING; SKIN BLISTER; RASH UNDER BREAST; HEADACHE; STOMACH PAIN; DIARRHEA; COUGH; BODY ACHES; FEVER; This spontaneous report received from a patient concerned a 52 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 21-JUN-2021) dose was not reported, administered on 10-APR-2021 12:30 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced cough. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced fever. Laboratory data included: Fever (NR: not provided) 100.7 F. Treatment medications included: guaifenesin, and paracetamol. On 11-APR-2021, the subject experienced stomach pain. On 11-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced skin peeling. On 14-APR-2021, the subject experienced skin blister. On 14-APR-2021, the subject experienced rash under breast. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, cough, body aches, headache, stomach pain, and diarrhea, and had not recovered from rash under breast, skin peeling, and skin blister. This report was non-serious.
Tremors for 2 hours Migraine for 2 hours Chills all day Body and joint aches all day Feeling hot for 2 hours Fatigue and tiredness all day Eye pain all day
pt recv vax & 16hr post vax pt died; pt seemed fine immed p/vax but few hours later devel sudden difficulty in breathing which resembled convuls; pt didn't breath properly & appeared to be convuls & would not burp;then went to sleep fast
During injection, majority of the vaccine was noted to leak from the hub and drip down pt's arm. Per "COVID-19 Vaccine Admininstration Errors and Deviations," If less than half of the dose was administered or the proportion of the dose cannot be estimated, the Interim Recommendation is to "administer the authorized dose immediately (no minimum interval) in the opposite arm." Situation was explained to pt and his son (per pt request), and both pt and son verbalized understanding. RxM notified. Authorized dose was immediately readministered in opposite arm, and pt and his son were counseled on  possible side effects.
Patient came to vaccine site on 4/23/21 to get second COVID Moderna vaccine.  He reported a stroke a day after his previous 1st dose Moderna on 3/24/21.  He was hospitalized with stroke and seizures.  He has a history of uncontrolled diabetes, high cholesterol, and triglycerides.  He smokes and has a history of cirrhosis.  Dr. spoke with the pt and approved the second dose administration.  No reactions documented following the vaccine.
itchiness; tingling feeling; welts all over body; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), PRURITUS (itchiness), PARAESTHESIA (tingling feeling) and URTICARIA (welts all over body) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 27-Mar-2021, the patient experienced PRURITUS (itchiness), PARAESTHESIA (tingling feeling) and URTICARIA (welts all over body). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (soreness in arm), PRURITUS (itchiness), PARAESTHESIA (tingling feeling) and URTICARIA (welts all over body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Fever to 102 rectally. Fever responded to TYLENOL. No other symptoms reported.
very fatigued, achy, headache, flushing, arm pain, nausea, "legs feel like jelly"
Sore throat, stuffy nose, runny nose, congestion, cough, headache, chills, fatigue.  Started with sore throat and quickly moved to the rest of the symptoms.  Note no fever.
severe joint pain and burning, fatigue, muscle pain for 12 hours; lymph node tenderness in neck and left underarm for 2 days
This spontaneous prospective pregnancy report as received from a nurse refers to a 24 year old female patient. The patient was 30 weeks pregnant and had Gestational diabetes. The patient had no known drug allergies. On 23-FEB-2016 the patient was vaccinated with a 0.5 ml dose of GARDASIL 9 lot number L016428, expiration date unknown) intramuscularly in left deltoid (Drug exposure during pregnancy, third trimester.). Concomitant medication included pre-natal vitamins only. The patient's estimated LMP was 28-JUL-2015 and EDD was 03-MAY-2016 (calculated by reported gestational week). The pregnancy outcome was pending. At the time of this reporting there was no adverse effects reported. Additional information has been requested.
About 6d after MMR pt developed low grade fever, chills, congestion, cough, glossitis.
AGE 67 at time of adverse event:  After 2nd vaccination, nickel size lump in left armpit/lymph gland.  Sick for 2 days. Fatigue.  Experienced shortness of breath in May 2021, syncope while golfing, very short of breath, rapid heartbeat.  During summer of 2021, regularly experienced shortness of breath (altitude of 3600), dizziness and fatigue.  Limited activity.  Bought smart watch end of August, left to go back home  and could monitor my oxygen level and heart rate.  Noted low oxygen levels sometimes (85%-90%).  Heart rate elevated.  Golfed at home and again had severe shortness of breath, rapid heartbeat (169) and had to quit golf.  Didn't feel well rest of day.  Stayed home in bed and two days later found out I could get an ECG read on my smart watch.  I went to demonstrate the ECG for the first time to my husband and it showed I was in Atrial Fibrillation.   I called my Cardiologist (who I had not seen since last visit over 3 years ago  I have a history of mitral prolapse) and booked an appointment for Sept. 24th, 2021.  At that appointment, Dr ordered a halter monitor for 30 days, an echocardiogram and had an EKG   at office. EKG was normal.  During the 30 day monitoring, I noted rapid heartbeat and shortness of breath at times.  I also noted some low oxygen levels.  Later Dr will note that he reviewed my phone and stated that on October 4th in the late morning hours, I was symptomatic with shortness of breath, dizziness and chest pain and there was evidence for an atrial arrhythmia. The tachycardia appears to have persisted for 40 minutes. Received Booster shot on Oct 6th and had a reaction of a quartersize swelling in left armpit/lymph gland (same arm as injection), fever, fatigue for 2 days.  On Nov. 9th, Dr discussed my results and put me on Cardizem to slow my heart rate down.  To this date, I am experiencing low oxygen and shortness of breath when walking up a hill or exerting myself.   My heartbeat only goes as high as 128 with shortness of breath and I then stop my activity.
Moderna Covid-19 Vaccine EUA  Reaction occurred about 10-15 minutes after injection.  Symptoms started with tingling of lips and mouth, swelling of lips, face, neck and tongue.  Swelling has started to subside but numbness of face, lips and tongue  continued with pins and needles sensation for several days